BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: . UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016;4:A157-720. [DOI: 10.1177/2050640616663689] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Bliesner A, Eccles-smith J, Bates C, Hayes O, Ho JY, Martins C, Truby H, Nitert MD. Impact of Food-Based Weight Loss Interventions on Gut Microbiome in Individuals with Obesity: A Systematic Review. Nutrients 2022;14:1953. [DOI: 10.3390/nu14091953] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chen X, Xu MT, Wen JB. Meta-analysis of vonoprazan and proton pump inhibitors in preventing delayed bleeding and facilitating ulcer healing after gastric endoscopic submucosal dissection. Shijie Huaren Xiaohua Zazhi 2020; 28(24): 1249-1260 [DOI: 10.11569/wcjd.v28.i24.1249] [Reference Citation Analysis]
3 Mousavi T, Nikfar S, Abdollahi M. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2020;16:583-604. [PMID: 32380874 DOI: 10.1080/17425255.2020.1767067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
4 Cazacu IM, Herman JM, Bhutani MS. Fiducial Placement for Guidance of Radiotherapy. Therapeutic Endoscopic Ultrasound 2020. [DOI: 10.1007/978-3-030-28964-5_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kornilova EB, Polyakova KI, Shkurko TV, Knyazev OV, Ermolaeva AD, Davydovskaya MV, Ermolaeva TN, Fisun AG. Economic rationale for administration of vedolizumab in patients with inflammatory bowel disease in Moscow. Dok gastroenterol 2019;8:55. [DOI: 10.17116/dokgastro2019803155] [Reference Citation Analysis]
6 . Heparin. Reactions Weekly 2018;1684:116-116. [DOI: 10.1007/s40278-018-40728-0] [Reference Citation Analysis]
7 . Azathioprine. Reactions Weekly 2018;1684:49-49. [DOI: 10.1007/s40278-018-40661-y] [Reference Citation Analysis]
8 . Multiple drugs with ciclosporin toxicity. Reactions Weekly 2018;1684:181-181. [DOI: 10.1007/s40278-018-40793-6] [Reference Citation Analysis]
9 . Influenza virus vaccine. Reactions Weekly 2018;1684:135-135. [DOI: 10.1007/s40278-018-40747-y] [Reference Citation Analysis]
10 . Multiple drugs. Reactions Weekly 2018;1684:174-174. [DOI: 10.1007/s40278-018-40786-7] [Reference Citation Analysis]
11 . Infliximab. Reactions Weekly 2018;1684:133-133. [DOI: 10.1007/s40278-018-40745-y] [Reference Citation Analysis]
12 Lo B, Prosberg MV, Gluud LL, Chan W, Leong RW, van der List E, van der Have M, Sarter H, Gower-Rousseau C, Peyrin-Biroulet L, Vind I, Burisch J. Systematic review and meta-analysis: assessment of factors affecting disability in inflammatory bowel disease and the reliability of the inflammatory bowel disease disability index. Aliment Pharmacol Ther 2018;47:6-15. [PMID: 28994131 DOI: 10.1111/apt.14373] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 6.2] [Reference Citation Analysis]
13 Malagelada C, Malagelada JR. Small Bowel Motility. Curr Gastroenterol Rep 2017;19. [DOI: 10.1007/s11894-017-0565-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]